GB9204780D0 - Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods - Google Patents
Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methodsInfo
- Publication number
- GB9204780D0 GB9204780D0 GB929204780A GB9204780A GB9204780D0 GB 9204780 D0 GB9204780 D0 GB 9204780D0 GB 929204780 A GB929204780 A GB 929204780A GB 9204780 A GB9204780 A GB 9204780A GB 9204780 D0 GB9204780 D0 GB 9204780D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccinia
- pharmaceuticals
- reagents
- methods
- expression products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929204780A GB9204780D0 (en) | 1992-03-05 | 1992-03-05 | Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods |
PCT/GB1993/000460 WO1993018153A1 (en) | 1992-03-05 | 1993-03-05 | Vaccinia virus b15r used in interleukin b1-involving condition |
AU36418/93A AU3641893A (en) | 1992-03-05 | 1993-03-05 | Vaccinia virus b15r used in interleukin b1-involving condition |
EP93905517A EP0656949A1 (en) | 1992-03-05 | 1993-03-05 | Vaccinia virus b15r used in interleukin b1-involving condition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929204780A GB9204780D0 (en) | 1992-03-05 | 1992-03-05 | Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9204780D0 true GB9204780D0 (en) | 1992-04-15 |
Family
ID=10711551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB929204780A Pending GB9204780D0 (en) | 1992-03-05 | 1992-03-05 | Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0656949A1 (en) |
GB (1) | GB9204780D0 (en) |
WO (1) | WO1993018153A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2330748T3 (en) * | 2003-08-07 | 2009-12-15 | F. Hoffmann-La Roche Ag | ANTIGENIC PEPTIDES OF REUMATOID ARTHRITIS (AR). |
EP1518932A1 (en) | 2003-09-29 | 2005-03-30 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Modified vaccinia virus Ankara (MVA) mutant and use thereof |
WO2020011754A1 (en) * | 2018-07-09 | 2020-01-16 | Transgene | Chimeric vaccinia viruses |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9023352D0 (en) * | 1990-10-26 | 1990-12-05 | Lynxvale Ltd | Vaccinia vectors,vaccinia genes and expression products thereof |
-
1992
- 1992-03-05 GB GB929204780A patent/GB9204780D0/en active Pending
-
1993
- 1993-03-05 EP EP93905517A patent/EP0656949A1/en not_active Withdrawn
- 1993-03-05 WO PCT/GB1993/000460 patent/WO1993018153A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0656949A1 (en) | 1995-06-14 |
WO1993018153A1 (en) | 1993-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9501874D0 (en) | Modified cutinases, dna, vector and host | |
HRP940175A2 (en) | Nucleic acid pharmaceuticals | |
AU3570193A (en) | Altered antibodies, products and processes relating thereto | |
HUP9700428A3 (en) | Targetcell-specific vectors for inserting genes, pharmaceuticals comprising such vectors and their use | |
AP9300494A0 (en) | Pharmaceuticals | |
HUP9603071A3 (en) | Purin-6-one derivatives, producing and pharmaceuticals preparations containing them | |
GB9023352D0 (en) | Vaccinia vectors,vaccinia genes and expression products thereof | |
HU9501771D0 (en) | Modified cutinases, dna, vector and host | |
GB9221468D0 (en) | Pharmaceuticals | |
GB8907468D0 (en) | Vaccinia vectors,vaccinia genes and expression products thereof | |
GB9204565D0 (en) | Pharmaceuticals | |
GB9219163D0 (en) | Pharmaceuticals | |
GB9205917D0 (en) | Pharmaceuticals | |
GB9214184D0 (en) | Pharmaceuticals | |
GB9204780D0 (en) | Vaccinia vectors,vaccinia genes,and expression products thereof;pharmaceuticals,reagents and methods | |
GB9206567D0 (en) | Dna analysis | |
AU6647494A (en) | Cytolysin gene and gene product | |
ZA941885B (en) | Nucleic acid pharmaceuticals | |
AU7122694A (en) | Dna sequence comprising at least two coat protein genes | |
ZA932047B (en) | Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-N-oxides, process for their preparations and their use as pharmaceuticals. | |
IE883270L (en) | Dna expression vectors | |
ZA932837B (en) | Pharmaceuticals. | |
GB9226165D0 (en) | Nucleic acid sequence | |
GB9202510D0 (en) | Pharmaceuticals | |
GB9221794D0 (en) | Pharmaceuticals |